EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 58.00
-0.60 (-1.02%)
At close: Feb 27, 2026
-30.46% (1Y)
| Market Cap | 1.71B |
| Revenue (ttm) | 425.75M |
| Net Income (ttm) | 29.34M |
| Shares Out | 29.53M |
| EPS (ttm) | 0.98 |
| PE Ratio | 59.20 |
| Forward PE | 31.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,593 |
| Average Volume | 40,548 |
| Open | 58.40 |
| Previous Close | 58.60 |
| Day's Range | 57.50 - 58.80 |
| 52-Week Range | 46.55 - 98.60 |
| Beta | 0.41 |
| RSI | 45.74 |
| Earnings Date | Feb 3, 2026 |